Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prognostic Significance of a Fragmented QRS Complex After Primary Percutaneous Coronary Intervention

NCT01136837 is registered in ClinicalTrials.gov with Bursa Postgraduate Hospital as lead sponsor.

NCT NCT01136837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01136837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prognostic Significance of a Fragmented QRS Complex After Primary Percutaneous Coronary Intervention
Lead sponsor
Bursa Postgraduate Hospital
Phase
Observational
Overall status
Completed
Start date
November 30, 2008
Completion date
May 31, 2009
Enrollment
85 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fragmented qrs, mace, primary pci